The HinduLean L·
Lupin takes 82.2% stake in Kaveri Therapeutics, licences 2 oncology assets for $1.6mn
LI has received 332,000 common shares in Kaveri, which will advance the oncology programme through global clinical trials
Read at The Hindu →
Business · 1 sources covering this
Lupin takes 82.2% stake in Kaveri Therapeutics, licences 2 oncology assets for $1.6mn
LI has received 332,000 common shares in Kaveri, which will advance the oncology programme through global clinical trials
Coverage spectrum
1 L · 0 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/ac1718d0fe3ea3a69b49d649feef0d127037c546" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Lupin takes 82.2% stake in Kaveri Therapeutics, licences 2 oncology assets for $1.6mn"></iframe>
